Colgate Palmolive (CL) Operating Expenses (2009 - 2026)

Colgate Palmolive's Operating Expenses history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• On a quarterly basis, Operating Expenses rose 9.38% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $8.1 billion, a 4.77% increase from a year earlier, with the FY2025 full-year figure at $7.9 billion, up 2.25% from the prior year.
• Operating Expenses steadied at $2.1 billion in Q1 2026 per CL's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Operating Expenses topped out at $2.1 billion in Q1 2026 and bottomed at $1.6 billion in Q4 2022.
• The 5-year median for Operating Expenses is $1.9 billion (2024), against an average of $1.8 billion.
• Across the five-year window, Operating Expenses gained 11.51% in 2023 and fell 0.94% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $1.6 billion in 2022, then gained by 10.41% to $1.8 billion in 2023, then increased by 5.16% to $1.9 billion in 2024, then rose by 9.18% to $2.1 billion in 2025, then advanced by 0.29% to $2.1 billion in 2026.
• Per Business Quant, the three latest CL Operating Expenses figures stand at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025).